Related references
Note: Only part of the references are listed.Whole-Genome DNA Methylation Sequencing Reveals Epigenetic Changes in Myelodysplastic Syndromes
Jing-dong Zhou et al.
FRONTIERS IN ONCOLOGY (2022)
Micro-RNA-125a mediates the effects of hypomethylating agents in chronic myelomonocytic leukemia
Johannes Lorenz Berg et al.
CLINICAL EPIGENETICS (2021)
Promoter Methylation of LEP and LEPR before and after Bariatric Surgery: A Cross-Sectional Study
Julia Wilhelm et al.
OBESITY FACTS (2021)
TET2 mutations are associated with hypermethylation at key regulatory enhancers in normal and malignant hematopoiesis
Morten Tulstrup et al.
NATURE COMMUNICATIONS (2021)
Clinical, molecular, and prognostic comparisons between CCUS and lower-risk MDS: a study of 187 molecularly annotated patients
Marissa Li et al.
BLOOD ADVANCES (2021)
Impact of obesity on survival of patients with myelodysplastic syndromes
Zaker Schwabkey et al.
HEMATOLOGY (2021)
Clonal hematopoiesis evolves from pretreatment clones and stabilizes after end of chemotherapy in patients with MCL
Christian Winther Eskelund et al.
BLOOD (2020)
Clinical impact of clonal hematopoiesis in patients with lymphoma undergoing ASCT: a national population-based cohort study
Simon Husby et al.
LEUKEMIA (2020)
Predictors of Survival and Time to Progression to Myeloid Neoplasm in Patients with Clonal Cytopenias
Ahmad Nanaa et al.
BLOOD (2020)
Myelodysplastic syndromes: 2018 update on diagnosis, risk-stratification and management
Guillermo Montalban-Bravo et al.
AMERICAN JOURNAL OF HEMATOLOGY (2018)
Mutations in idiopathic cytopenia of undetermined significance assist diagnostics and correlate to dysplastic changes
Jakob Werner Hansen et al.
AMERICAN JOURNAL OF HEMATOLOGY (2016)
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
Daniel A. Arber et al.
BLOOD (2016)
Obesity over the life course and risk of acute myeloid leukemia and myelodysplastic syndromes
Jenny N. Poynter et al.
CANCER EPIDEMIOLOGY (2016)
Obesity and cancer: inflammation bridges the two
Ryan Kolb et al.
CURRENT OPINION IN PHARMACOLOGY (2016)
The Systemic Profile of Soluble Immune Mediators in Patients with Myelodysplastic Syndromes
Astrid Olsnes Kittang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes
David P. Steensma et al.
BLOOD (2015)
The genetic basis of myelodysplasia and its clinical relevance
Mario Cazzola et al.
BLOOD (2013)
Clinical and biological implications of driver mutations in myelodysplastic syndromes
Elli Papaemmanuil et al.
BLOOD (2013)
Body size in relation to incidence of subtypes of haematological malignancy in the prospective Million Women Study
F. Murphy et al.
BRITISH JOURNAL OF CANCER (2013)
Impact of serum adiponectin and leptin levels in acute leukemia
Salah Aref et al.
HEMATOLOGY (2013)
Obesity but not overweight increases the incidence and mortality of leukemia in adults: A meta-analysis of prospective cohort studies
Jorge J. Castillo et al.
LEUKEMIA RESEARCH (2012)
Cytokine signature profiles in acquired aplastic anemia and myelodysplastic syndromes
Xingmin Feng et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
Unraveling the Molecular Pathophysiology of Myelodysplastic Syndromes
Rafael Bejar et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Obesity, Lifestyle Factors, and Risk of Myelodysplastic Syndromes in a Large US Cohort
Xiaomei Ma et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2009)
Aberrant DNA methylation is a dominant mechanism in MDS progression to AML
Ying Jiang et al.
BLOOD (2009)
MDS and secondary AML display unique patterns and abundance of aberrant DNA methylation
Maria E. Figueroa et al.
BLOOD (2009)
Expression patterns of leptin receptor (OB-R) isoforms and direct in vitro effects of recombinant leptin on OB-R, leptin expression and cytokine secretion by human hematopoietic malignant cells
Athanasia Mouzaki et al.
CYTOKINE (2009)
Mechanisms of Disease: Myelodysplastic Syndromes.
Ayalew Tefferi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Serum leptin level in acute myeloid leukemia patients
M. Yilmaz et al.
HEMATOLOGY (2008)
Circulating adiponectin and leptin in relation to myelodysplastic syndrome: A case-control study
Maria Dalamaga et al.
ONCOLOGY (2007)
Impact of anemia on hospitalization and mortality in older adults
Bruce F. Culleton et al.
BLOOD (2006)
Obesity and cancer risk among white and black United States veterans
C Samanic et al.
CANCER CAUSES & CONTROL (2004)
Association of obesity and cancer risk in Canada
SY Pan et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2004)
Overweight, obesity and cancer: Epidemiological evidence and proposed mechanisms
EE Calle et al.
NATURE REVIEWS CANCER (2004)
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults
EE Calle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Prevention of leptin binding to its receptor suppresses rat leukemic cell growth by inhibiting angiogenesis
PO Iversen et al.
BLOOD (2002)
Share Paper
